Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | PLG | P00747 | 3/20 | 0.34 |
| ▸ | PLAU | P00749 | 2/20 | 0.34 |
| ▸ | F2 | P00734 | 1/20 | 0.34 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | F10 | P00742 | 1/20 | 0.32 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.32 |
| ▸ | KLK7 | P49862 | 2/20 | 0.32 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.32 |
| ▸ | CTSK | P43235 | 3/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.32 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15407157 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRPLGPLAUF2 | |
| SCHEMBL29400475 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRPLGPLAUF2 | |
| SCHEMBL27429599 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRPLGPLAUF2 | |
| SCHEMBL20561238 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRPLGPLAUF2 | |
| SCHEMBL16893643 | 0.98 | ALDH1A1 (0.41) | ALDH1A1TSHRPLGPLAUF2 | |
| SCHEMBL31058628 | 0.97 | ALDH1A1 (0.37) | ALDH1A1TSHRPLGPLAUF2 | |
| SCHEMBL30918351 | 0.94 | ALDH1A1 (0.35) | ALDH1A1TSHRPLGPLAUF2 | |
| SCHEMBL17154024 | 0.94 | PLG (0.34) | ALDH1A1TSHRPLGPLAUF2 | |
| SCHEMBL30918344 | 0.94 | ALDH1A1 (0.35) | ALDH1A1TSHRPLGPLAUF2 | |
| SCHEMBL31235336 | 0.93 | ALDH1A1 (0.38) | ALDH1A1TSHRPLGPLAUF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3934635-B1 | COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF | ENSYSCE BIOSCIENCES INC (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-3355885-B1 | POLYSUBUNIT OPIOID PRODRUGS RESISTANT TO OVERDOSE AND ABUSE | ELYSIUM THERAPEUTICS INC (US) | 2026-02-25 | — | — | EP | disclosed |
| EP-4692086-A1 | ANTICOAGULATION REVERSAL AGENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shaanxi Micot Pharmaceutical Technology Co., Ltd. (CN) | 2026-02-11 | — | — | EP | disclosed |
| EP-4321524-B1 | LIPID AND COMPOSITION | SOGO PHARM (JP) | 2025-12-10 | — | — | EP | disclosed |
| US-12466784-B2 | Analogs of pterostilbene amino acid bearing carbonates for treating a non-alcoholic fatty liver disease and nonalcoholic steatohepatitis | APICAL MOLECULAR BIOTECH CO., LTD. (TW) | 2025-11-11 | — | — | US | disclosed |
| US-20250326807-A1 | CALPROTECTIN BINDING PEPTIDES | BUEHLMANN LABORATORIES AG (CH) | 2025-10-23 | — | — | US | disclosed |
| EP-4136063-B1 | NOVEL ANALOGS OF PTEROSTILBENE AMINO ACID BEARING CARBONATES FOR TREATING A NON-ALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS | APICAL MOLECULAR BIOTECH CO LTD (TW) | 2025-10-22 | — | — | EP | disclosed |
| US-20250304645-A1 | Prodrugs of GLP-1 Polypeptide and Uses Thereof | NOVO NORDISK A/S (DK) | 2025-10-02 | — | — | US | disclosed |
| US-12312621-B2 | Reprogramming urokinase into an antibody-recruiting anticancer agent | YALE UNIVERSITY (US) | 2025-05-27 | — | — | US | disclosed |
| US-20250161468-A1 | POLYSUBUNIT OPIOID PRODRUGS RESISTANT TO OVERDOSE AND ABUSE | ELYSIUM THERAPEUTICS, INC. | 2025-05-22 | — | — | US | disclosed |
| EP-3131566-B1 | BI-TERMINAL PEGYLATED INTEGRIN-BINDING PEPTIDES AND METHODS OF USE THEREOF | UNIV CALIFORNIA (US) | 2022-10-05 | — | — | EP | disclosed |
| WO-2022185319-A1 | UBIQUITIN LIGASE KPC1-PEPTIDE BASED PROTEOLYSIS TARGETING CHIMERAS (PROTAC) AND USES THEREOF | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2022-09-09 | — | — | WO | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| US-11400062-B2 | Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof | SIGNATURE THERAPEUTICS, INC. (US) | 2022-08-02 | — | — | US | disclosed |
| WO-2022136366-A1 | NOVEL METHOD FOR SYNTHESIZING NCA COMPOUNDS | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE MONTPELLIER (ENSCM) (FR) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022133069-A1 | PEPTIDOMIMETIC MATRIPTASE 2 INHIBITORS AND USES THEREOF | DISC MEDICINE, INC. (US) | 2022-06-23 | — | — | WO | disclosed |
| US-20220175699-A1 | COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF | 3I, LP | 2022-06-09 | — | — | US | disclosed |
| US-20220107246-A1 | NONCOVALENT TAGS AND RELATED METHODS FOR CYTOSOLIC DELIVERY OF MACROBIOMOLECULES | UNIVERSITY OF WASHINGTON (US) | 2022-04-07 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
| US-20220062371-A1 | LIGAND-DRUG-CONJUGATES AS SUBSTRATES FOR SELECTIVE CLEAVAGE BY THE EXOPEPTIDASE ACTIVITY OF CATHEPSIN B | DEBIOPHARM RESEARCH & MANUFACTURING S.A. (CH) | 2022-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220062371-A1 | LIGAND-DRUG-CONJUGATES AS SUBSTRATES FOR SELECTIVE CLEAVAGE BY THE EXOPEPTIDASE ACTIVITY OF CATHEPSIN B | CTSB, CTSE, CTSV | ALDH1A1 2519/4885TSHR 2042/4885PLG 180/4885 |
| US-20250161468-A1 | POLYSUBUNIT OPIOID PRODRUGS RESISTANT TO OVERDOSE AND ABUSE | OPRM1, OPRK1, OPRL1 | ALDH1A1 292/4885TSHR 4303/4885PLG 728/4885 |
| US-12466784-B2 | Analogs of pterostilbene amino acid bearing carbonates for treating a non-alcoholic fatty liver disease and nonalcoholic steatohepatitis | FABP1, GLS2, SLC1A5 | ALDH1A1 1721/4885TSHR 3419/4885PLG 1425/4885 |
| US-12312621-B2 | Reprogramming urokinase into an antibody-recruiting anticancer agent | PLAUR, CD47, CD14 | ALDH1A1 3594/4885TSHR 1054/4885PLG 10/4885 |
| US-20220175699-A1 | COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF | ACHE, DNPEP, ACE | ALDH1A1 2381/4885TSHR 3098/4885PLG 463/4885 |
| US-11400062-B2 | Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof | ACHE, COMT, CES2 | ALDH1A1 795/4885TSHR 3797/4885PLG 443/4885 |
| US-20250304645-A1 | Prodrugs of GLP-1 Polypeptide and Uses Thereof | GLP1R, IAPP, GCG | ALDH1A1 1250/4885TSHR 1690/4885PLG 174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.